Sterling Capital Management LLC Acquires 1,742 Shares of InMode Ltd. (NASDAQ:INMD)

Sterling Capital Management LLC boosted its holdings in shares of InMode Ltd. (NASDAQ:INMD) by 23.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 9,162 shares of the healthcare company’s stock after acquiring an additional 1,742 shares during the period. Sterling Capital Management LLC’s holdings in InMode were worth $153,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in INMD. Barclays PLC raised its holdings in shares of InMode by 113.5% in the 3rd quarter. Barclays PLC now owns 169,630 shares of the healthcare company’s stock worth $2,876,000 after acquiring an additional 90,173 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of InMode by 0.6% during the third quarter. Geode Capital Management LLC now owns 1,101,951 shares of the healthcare company’s stock valued at $18,678,000 after purchasing an additional 6,282 shares in the last quarter. Virtu Financial LLC purchased a new position in shares of InMode in the 3rd quarter worth about $219,000. Tidal Investments LLC raised its stake in shares of InMode by 4.6% in the third quarter. Tidal Investments LLC now owns 71,039 shares of the healthcare company’s stock valued at $1,204,000 after buying an additional 3,140 shares during the period. Finally, Franklin Resources Inc. increased its holdings in InMode by 4.6% in the 3rd quarter. Franklin Resources Inc. now owns 17,559 shares of the healthcare company’s stock worth $292,000 after acquiring an additional 768 shares during the last quarter. 68.04% of the stock is owned by institutional investors.

InMode Stock Down 0.8 %

Shares of NASDAQ INMD opened at $14.80 on Tuesday. The stock’s 50-day simple moving average is $17.60 and its two-hundred day simple moving average is $17.63. InMode Ltd. has a twelve month low of $13.68 and a twelve month high of $19.85. The firm has a market capitalization of $1.03 billion, a P/E ratio of 6.30 and a beta of 1.96.

Analysts Set New Price Targets

Several equities research analysts have commented on INMD shares. Needham & Company LLC reaffirmed a “hold” rating on shares of InMode in a report on Wednesday, April 9th. Barclays lifted their price objective on shares of InMode from $26.00 to $29.00 and gave the company an “overweight” rating in a research note on Wednesday, February 5th. Finally, Jefferies Financial Group dropped their target price on InMode from $16.00 to $15.00 and set a “hold” rating on the stock in a research report on Monday, April 14th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $21.25.

InMode Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.